Molecular and endoscopic surveillance of Barrett's esophagus

Molecular and endoscopic surveillance of Barrett's esophagus - Molecular and endoscopic surveillance of Barrett's esophagus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000000937

Enrollment

100

Registered

2007-12-07

Start date

2007-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reflux esophagitis,Barrett&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility criteria is the following. 1.Patient who have atended a Keio University Hospital 2.Patient who have Reflux esophagitis or Barrett's epithelium or Barrett's esophagus 3.Patient who provide weitten informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria is the following. 1.Patient who have medical history of an upper gastrointestinal tract disease 2.Patient who have other severe diseases 3.Patient who take some anticoagulant or antiplatelet drugs and who cannnot stop it.

Design outcomes

Primary

Measure	Time frame
Relasion between carcinogenesis of the esophageal adenocarcinoma from Barrett's esophagus and DNA methylation, a change of microRNA expression, oxidation stress marker,metabolic marker.	—

Countries

Japan

Contacts

Public ContactHidekazu Suzuki

Keio University Division of Gastroenterology,Department of Internal Medicine

hsuzuki@sc.itc.keio.ac.jp03-3353-1211

Outcome results